Analyst Ratings for Impax Laboratories (IPXL)
IPXL Rating Summary
IPXL Price Target Summary
- Highest: $30.00 (Collins Stewart)
- Lowest: $16.00 (Leerink Swann)
- Average: $23.00
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$23.00 (+24.3%)
Avg. $ Target:
$23.00 (+24.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2013 | Leerink Swann | Downgrade | Market Perform (Outperform) |
16.00 (23.00) |
16.00 | 18.51 | 15.69% | Details |
| 3/5/2013 | Canaccord Genuity | Downgrade | Hold (Buy) |
20.00 (25.00) |
16.00 | 18.51 | 15.69% | Details |
| 9/25/2012 | ThinkEquity | Downgrade | Hold (Buy) |
25.00 (25.00) |
26.64 | 18.51 | -30.52% | Details |
| 9/18/2012 | Guggenheim | New Coverage | Buy (N/A) |
30.00 (N/A) |
24.05 | 18.51 | -23.04% | Details |
| 4/17/2012 | Auriga » Updated 5/14/2012 |
New Coverage | Buy (N/A) |
30.00 (N/A) |
23.71 | 18.51 | -21.93% | Details |
| 9/22/2011 | Goldman Sachs » Updated 7/6/2012 |
Downgrade | Sell (N/A) |
19.00 (20.00) |
20.91 | 18.51 | -11.48% | Details |
| 6/8/2011 | JPMorgan | Downgrade | Neutral (N/A) |
N/A (N/A) |
23.49 | 18.51 | -21.2% | Details |
| 5/31/2011 | RBC Capital | Downgrade | Sector Perform (N/A) |
N/A (N/A) |
27.18 | 18.51 | -31.9% | Details |
| 4/15/2011 | UBS » Updated 3/7/2013 |
New Coverage | Neutral (N/A) |
17.00 (23.00) |
27.23 | 18.51 | -32.02% | Details |
| 3/15/2011 | Cowen | Upgrade | Outperform (N/A) |
N/A (N/A) |
22.07 | 18.51 | -16.13% | Details |
| 9/14/2010 | Jefferies » Updated 6/25/2012 |
Downgrade | Hold (N/A) |
20.00 (21.00) |
18.37 | 18.51 | 0.76% | Details |
